Supplement Maker Wins Verdict Over Imitator in Federal Court

<b>Supplement Maker Wins Verdict Over Imitator in Federal Court</b>“></td>
<td>
<p>(<a href=NewsUSA) – After a seven-day trial, a federal jury in Colorado rendered a verdict finding that Allergy Research Group (ARG), a subsidiary of the Kikkoman Corp. (OTC: KIKOF.PK), violated federal false advertising laws in marketing their product, “Russian Choice Immune,” as identical to the immune system support supplement Del-Immune V, previously marketed by ARG as Delta-Immune. The jury also determined that ARG misled buyers as to the product’s origin — Russian Choice Immune was actually developed and manufactured in Vietnam — then sent it to the U.S. without conducting any prior research, according to the testimony of ARG’s own expert, Dr. Ba Hoang.

Del-Immune V is a unique probiotic supplement made from the “good bacteria” lactobacillus rhamnosus (DV strain), authored in the Ukraine by Dr. Lubov Shynkarenko, Del-Immune vice president and former dean of the Biotechnology Institute at Kiev’s elite National Technical University.

Manufactured by Boulder-based Pure Research Products LLC (PRP), the Del-Immune V dietary supplement provides immediate immune system support, helping the body defend itself from environmental invaders such as viruses and germs. It is also used to help the body deal with other health issues by strengthening the body’s natural immune response.

When the probiotic’s cells break, they release immune-activating proteins that immediately prepare the immune system to fight foreign invaders. Those taking the supplement boost their general immune response, as well as more adequately prepare their bodies to resist germs and bugs.

Del-Immune represents the culmination of 50 years of research originated by Cold War-era Soviet Bloc scientists and Russian military bio-warfare troop protection programs. PRP obtained exclusive rights to manufacture, distribute and market the DV strain from its Russian partners in 2002.

“We conducted analysis of the counterfeit product and found that it did not have the characteristics of Del-Immune V,” said John Sichel, pharmacist and Del-Immune founder. “While we’re flattered that they would want to copy one of the most thoroughly researched and effective immune system supplements in the world, we’re happy that the jury recognized that this was confusing customers who want the immune system benefits of American-made Del-Immune V.”

Del-Immune V is used by thousands and recommended by doctors around the world. For more information, please visit www.del-immune.com.

The Earlier, the Better: Building Immune Defenses Against H1N1

<b>The Earlier, the Better: Building Immune Defenses Against H1N1</b>“></td>
<td>
<p>(<a href=NewsUSA) – Recently, scientists discovered that the 2009 H1N1 Swine Flu virus is more like the H5N1 avian flu than the historic 1918 pandemic H1N1 Spanish flu strain, and that current mutations of the virus have rendered previous flu vaccines less effective.

In a teleconference with colleagues, Dr. Roger Mazlen, an internist in Rosyln Heights, NY, discussed the current Swine Flu outbreaks. Aside from traditional medical school, Dr. Mazlen received specialized training at the National Institute for Health (NIH) and is the former Clinical Research Director for Immunotec, Ltd. in Canada. He has practiced internal medicine and nutrition for more than 30 years.

Swine flu, or H1N1, was first isolated in a pig in 1930, according to the Centers for Disease Control and Prevention. The virus has demonstrated an ability to migrate from domestic pigs to humans. Dr. Mazlen said there are several factors contributing to the current swine flu outbreak, including environmental, cultural and economic issues. “The current recession, loss of retirement funds, compromised nutrition, reduced exercise, obesity and other factors produce immune depression. A depressed immune system cannot fight off the invasion of viral and other pathogens that attempt to find a home to set up infections in our bodies,” he says.

Dr. Mazlen suggests protection strategies for a potentially larger H1N1 outbreak during the 2009 through 2010 flu season. “Frequent hand washing is a start. Also, lots of daily water helps to hydrate the body and assist the immune system,” he said. Vitamin and mineral supplements add fortification, but Dr. Mazlen suggested also adding fish oil because of its clinically-proven immune function support. Fish oil blends are available as gel capsules or in liquid form at health food stores, and several different brands are also available at www.puritan.com.

Dr. Mazlen said that Tamiflu, the currently recommended prescription medication used in flu and Swine flu, is most effective when used within a few hours of the first viral symptoms. But Swine Flu, as reported by the CDC, has an ability to mutate within hours. Tamiflu may be effective for Swine Flu in the morning, and may be ineffective by the end of the day because of viral mutation.

When asked whether the popular herbal remedy Echinacea could be effective, Dr. Mazlen explained that studies have proven the product has minimal effectiveness in stimulating the immune response. He said he prefers a natural immune-stimulating product that he has used with over 500 patients, including his family members. The product was originally developed in Russia but is now made in the U.S. Dr. Mazlen said he has had good results during the past years with patients fighting flu and other infections. The product, Del-Immune V, is available at www.delimmune.com.

Early measures to protect health might be the key to minimizing potentially serious infections this flu season. Dr. Mazlen closed the discussion by expressing his concern over whether it is Swine Flu H1N1 or a mutated form of the Swine Flu. “It is important to have an immune defense strategy this year — the earlier the better,” he said.